Accredited InvestorsEmployee ShareholdersInstitutionsPrivate Companies Who We Serve Trading and Investing Data Solutions Private Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Browse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunities​Forge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All Insights Private Market Reports Market Insights Buying and Selling Pre-IPO​ All Reports​Private Market UpdatesForge Investment OutlookStartup News and Trends​Private Market Data and Analytics​Tech IPO Calendar for 2024​Private Market Explained​Buying Pre-IPO Shares​Selling Pre-IPO SharesGlossaryVideosFAQsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
Solutions
Insights
About
Who We Serve
Solutions
Trading and Investing
Institutional Trading
Individual Investing
Data Solutions
Private Asset Custody
Self-Directed IRA
Insights
Private Market Reports
Market Insights
Buying and Selling Pre-IPO​
About
Log In
Sign Up
Secondary Marketplace / Trade Private Companies / Buy and Sell Elucid Stock

Elucid Stock

www.elucid.com/Healthcare / Healthcare softwareFounded: 2009

Elucid is a diagnostic imaging company that uses artificial intelligence to improve vascular patient outcomes. With a mission to prevent cardiovascular disease and improve pathology accuracy, Elucid optimizes clinical precision with arterial plaque analysis. Elucid also features ct angiography, FFRct, plaque characterization, and non-coding transcripts. Elucid was founded by Andrew J. Buckler in 2013 and is headquartered in Boston, MA.

Buy or sell Elucid stockLearn more about Elucid IPO

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Elucid, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Elucid’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Elucid.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Elucid investors also invested in these private companies

National Institutes of Health
IAG Capital Partners
Global Health Investment Fund
Elevage Medical Technologies
Aphelion Capital
Biovision Ventures
Philips Ventures
BlueStone Venture Partners
Bold Brain Ventures
Ice Age Gold
MedTex Ventures
Willamette Valley Capital
University of Michigan Endowment

Team

Management Team

Blake Richards
Chief Executive Officer
Andrew Miller
Chief Technology Officer & Senior Vice President Engineering
Scott Burger
Chief Commercial Officer
James Hamilton Ph.D
Co-Founder
Andrew Buckler
Co-Founder
Todd Villines
Chief Medical Officer

Board Members

Evan Melrose MD
Elevage Medical Technologies
Kelly Huang Ph.D
Elevage Medical Technologies

Elucid stock FAQs

plusminus

Can you buy Elucid stock?

As Elucid is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Elucid, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Elucid stock?

To invest in a private company like Elucid through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Elucid stock?

Yes, you may be able to sell your Elucid stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Elucid stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Elucid stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Elucid a public company?

No, Elucid is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Elucid’s stock price?

Elucid is a privately held company and therefore does not have a public stock price. However, you may access Elucid’s private market stock price with Forge Data.
plusminus

What is Elucid’s stock ticker symbol?

Elucid does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Elucid in the Healthcare software sector

Innovaccer
Sector
Healthcare / Healthcare software
Last Round Est. Valuation
$4B
Rad AI
Sector
Healthcare / Healthcare software
Last Round Est. Valuation
$276.13MM
Huma
Sector
Healthcare / Healthcare software
Last Round Est. Valuation
$731.49MM
Abridge
Sector
Healthcare / Healthcare software
Last Round Est. Valuation
$845.13MM
HealthJoy
Sector
Healthcare / Healthcare software
 
 
nference
Sector
Healthcare / Healthcare software
Last Round Est. Valuation
$858.38MM
Paige
Sector
Healthcare / Healthcare software
Last Round Est. Valuation
$656.14MM
Hippocratic AI
Sector
Healthcare / Healthcare software
 
 
Insilico Medicine
Sector
Healthcare / Healthcare software
 
 
Fierce Biotech 11/13/2023

Elucid collects $80M for AI-powered mapping of blocked arteries

The cardiovascular imaging company Elucid has made it clear they mean to deliver on their promise of artificial intelligence-powered exams to chart the insides of blocked arteries. And now they’ve raised $80 million to do so. Financially speaking, the startup has kept up its momentum since last year’s venture capital fundraising—with a $27 million series B in June 2022, which just about tripled its $8 million round from the year before. The most recent series C continues that trajectory, for a total of $121 million since Elucid’s founding.
Mobi Health News 11/10/2023

Elucid scores $80M for AI imaging analysis software and more digital health fundings

AI company Elucid had a series C funding round which raised $80 million.
Browse More Insights
Trending Companies

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.